Brain Death

Markers of brain injury developed due to COVID-19 were found in patients even months after the infection and despite blood tests measuring inflammation returning normal results, according to a new research. Researchers from universities in the UK explained that during the acute phase of the viral infection, when symptoms develop quickly, key inflammatory proteins and brain injury markers are produced. They analysed over 800 hospitalised patients' samples from across England and Wales. Surprisingly, even months after being discharged from the hospital, there is on-going robust biomarker evidence of brain injury developed due to COVID-19, the researchers said in their study published in a journal, Nature Communications. The biomarker evidence was more prominently seen in patients experiencing neurological dysfunction during the acute illness, and continued in the recovery phase in patients suffering acute neurological complications, the researchers said. "While some neurological ...

One of the four doctors of the medical panel, authorised to declare a patient brain-dead, should be from the government service, the guidelines added